Medicine research news Return to previous page
Article Released Mon-4th-June-2018 10:00 GMT
Contact: Izumi Mindy Takamiya Institution: Institute for Integrated Cell-Material Sciences at Kyoto University
 A major step towards individualized cancer therapy

Successful replication of ovarian tumours inside chicken eggs heralds a new era for patient-centred cancer treatment.

Image Name
The team opened a small window in eggshells and implanted ovarian tumour cells on top of the vascular membrane surrounding 10-day-old chicken embryos.
Copyright : Izumi Mindy Takamiya
Fuyuhiko Tamanoi of Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) and colleagues in the US succeeded in establishing a versatile, powerful and convenient model to analyse human cancer.

They developed a ‘chicken egg tumour model’ in which cultured ovarian cancer cells are transplanted on top of the membrane that surrounds a 10-day-old chicken embryo. An ovarian tumour forms on top of the membrane within three days of transplantation.

The team had similar results when they used ovarian cancer cells taken directly from patients, showing that their chicken egg model provides a convenient system for replicating human cancer. This conclusion is supported by their detailed characterization of the tumour, demonstrating that it possesses all major cancer features.

“We were surprised when the tumour was formed in three days,” says Tamanoi. “ This is very rapid considering that it takes weeks to do the same with mice. We can start using this model to test for anti-cancer drugs tailored to each cancer patient’s needs. The process can be completed within one week,” he says. This is a major step toward individualized medicine for cancer patients.

Tamanoi’s team, in collaboration with colleagues in France and Saudi Arabia, also developed a new type of biodegradable silica nanoparticle called ‘biodegradable PMO’, which is only 200 nanometres in size. The nanoparticles were loaded with the anti-cancer drug doxorubicin and were tested on human ovarian tumour established in the chicken egg.

The biodegradable PMO carrying doxorubicin quickly eliminated the human ovarian tumours without affecting other organs in the chicken embryo. When a smaller amount of the drug, not enveloped in the nanoparticles, was injected in the egg, severe organ damage ensued. This indicates that the team’s nanoparticles prevent anti-cancer drug side effects due to their ability to directly target the tumour.

The chicken egg model has several advantages over existing models, such as mouse models, for testing anti-cancer therapies. The tumours form much more rapidly on the chicken embryonic membranes than in mice due to the rich nutrient environment and the incomplete immune system at this stage of embryonic development. Fertilized chicken eggs are also less expensive to use than immune-compromised mice making the model suitable for high throughput experiments.

For more information about this research, contact
Fuyuhiko Tamanoi
fuyut@microbio.ucla.edu

DOI: 10.1038/s41598-018-25573-8

About Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS)
At iCeMS, our mission is to explore the secrets of life by creating compounds to control cells, and further down the road to create life-inspired super materials that confront the myriad problems that afflict modern society. In only a decade, collaborative research at iCeMS has resulted in significant cutting-edge scientific discoveries, and the creation of over 1500 unique materials. We will keep turning our inspirations into purposeful, transformative innovations for the practical benefit of society.

For more information about iCeMS, contact

Izumi Mindy Takamiya
itakamiya@icems.kyoto-u.ac.jp
Image Name
Researchers developed a faster and cheaper way to test cancer drugs to develop patient-specific treatments.
Copyright : Kyoto University iCeMS

Associated links

Keywords associated to this article:
Create Account...